Handelsinvest Investeringsforvaltning Sangamo Therapeutics, Inc Transaction History

Handelsinvest Investeringsforvaltning

  • $208 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$9.51 - $16.6 $1.19 Million - $2.08 Million
-125,000 Closed
0 $0
Q3 2018

Oct 23, 2018
BUY
$13.05 - $19.05 $326,250 - $476,250
25,000 Added 25.0%
125,000 $2.12 Million
Q2 2018

Aug 09, 2018
BUY
$13.9 - $19.8 $1.39 Million - $1.98 Million
100,000 New
100,000 $1.42 Million

Others Institutions Holding SGMO

# of Institutions
141
Shares Held
60.4M
Call Options Held
1.46M
Put Options Held
1.84M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $132M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email